On August 1, 2025, Adial Pharmaceuticals, Inc. entered into a sales agreement to sell up to $4,983,000 of its common stock through A.G.P./Alliance Global Partners, replacing a previous sales agreement terminated on July 31, 2025. Previously, the company raised approximately $4,000,000 by selling 2,348,520 shares under the terminated agreement.